{"id":"gsk1838262-placebo-match","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL5590462","moleculeType":null,"molecularWeight":"1608.96"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As a placebo match, GSK1838262 contains no active pharmaceutical ingredient and is formulated to be indistinguishable from the corresponding active drug in terms of appearance, taste, texture, and administration route. It is used in randomized controlled trials to maintain blinding and reduce bias in efficacy and safety assessments.","oneSentence":"GSK1838262 is a placebo match formulation designed to mimic the appearance and administration of an active pharmaceutical agent for use in blinded clinical trials.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:39:55.895Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT01668667","phase":"PHASE4","title":"Gabapentin Enacarbil (GSK1838262) Adult Restless Leg Syndrome (RLS) Post Marketing Commitment Study","status":"COMPLETED","sponsor":"XenoPort, Inc.","startDate":"2012-06","conditions":"Restless Legs Syndrome","enrollment":501},{"nctId":"NCT01411124","phase":"PHASE1","title":"Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects","status":"COMPLETED","sponsor":"XenoPort, Inc.","startDate":"2011-06","conditions":"Restless Legs Syndrome (RLS)","enrollment":36}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"GSK1838262 Placebo match","genericName":"GSK1838262 Placebo match","companyName":"XenoPort, Inc.","companyId":"xenoport-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}